Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
IVXA-12 by Icosavax for Respiratory Syncytial Virus (RSV) Infections: Likelihood of Approval
IVXA-12 is under clinical development by Icosavax and currently in Phase II for Respiratory Syncytial Virus (RSV) Infections. According to...
Data Insights
IVXA-12 by Icosavax for Human Metapneumovirus Infections: Likelihood of Approval
IVXA-12 is under clinical development by Icosavax and currently in Phase II for Human Metapneumovirus Infections. According to GlobalData, Phase...